Proprietary Drugs 1
Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts) · United Kingdom
Key facts
- Contract value
- €15,340,415
- Awarded
- 05 Jun 2019
- Contract starts
- 01 Jul 2019
- Contract ends
- 30 Jun 2021
- Procedure
- Open procedure
- Buyer type
- Health
Awarded to 42 suppliers
| Supplier | Value |
|---|---|
| Abbvie Ltd | €15,340,414 |
| Accord Healthcare Ltd | €15,335,916 |
| Allergan Pharmaceuticals | €15,335,916 |
| Alliance Pharmaceuticals Ltd | €15,335,916 |
| AMO United Kingdom | €15,335,916 |
| AOP Orphan Pharmaceuticals AG | €15,335,916 |
| Aspen Pharma Ireland Ltd | €15,335,916 |
| Atnahs PharmaUK Ltd | €15,335,916 |
| Bausch and Lomb Ltd | €15,335,916 |
| Baxter Health Care Ltd | €15,335,916 |
| Bayer plc | €15,335,916 |
| Bristol-Myers Squibb Pharmaceuticals Ltd | €15,335,916 |
| Chiesi Limited | €15,335,916 |
| Creo Pharma Ltd | €15,335,916 |
| Dr Falk Pharma UK Ltd | €15,335,916 |
| Focus Pharmaceuticals Ltd | €15,335,916 |
| FRESENIUS KABI LIMITED | €15,335,916 |
| Gilead Sciences Limited | €15,335,916 |
| Glaxo Smithkline | €15,335,916 |
| Glenmark Pharmaceuticals | €15,335,916 |
| hameln pharma ltd | €15,335,916 |
| Janssen Limited | €15,335,916 |
| Martindale | €15,335,916 |
| Mercury Pharmaceuticals Limited | €15,335,916 |
| Merz Pharma UK Ltd | €15,335,916 |
| Mylan | €15,335,916 |
| NAPP PHARMACEUTICAL GROUP LIMITED | €15,335,916 |
| Novartis Pharmaceuticals UK Ltd | €15,335,916 |
| Novo Nordisk Pharmaceuticals Ltd | €15,335,916 |
| Orion Pharma (UK) Ltd | €15,335,916 |
| Pfizer Ltd | €15,335,916 |
| Ranbaxy UK Ltd (Sun Pharma) | €15,335,916 |
| Reckitt Benckiser Healthcare (UK) Ltd | €15,335,916 |
| Roche Products Ltd | €15,335,916 |
| Sandoz Ltd | €15,335,916 |
| Sanofi | €15,335,916 |
| Syri Ltd | €15,335,916 |
| Teva UK Ltd | €15,335,916 |
| Thornton & Ross Ltd | €15,335,916 |
| Tillomed Laboratories ltd | €15,335,916 |
| Wockhardt UK Limited | €15,335,916 |
| Zentiva Pharma UK Ltd | €15,335,916 |
Categories (CPV)
- 33600000 Pharmaceutical products
Similar open tenders
Global Travel, Accommodation and Venue Management Services
Location: North WestBuyer: Government Commercial Agency
Open tenderCloses 8 Dec, 202634 daysValue £36.25bnSource Find a TenderA framework providing comprehensive booking solutions for all UK Public Sector Travel needs, including air, rail, taxis, coaches, car hire, accommodation and venues for meetings, conferences and events, as well as emergency travel and accommodation solutions, including for civilian cohorts under the care of a UK Public
National Generic Pharmaceuticals – Project Revive
Location: LondonBuyer: NHS England
Open tenderCloses 30 Nov, 202626 daysValue £6.86mSource Find a TenderNational Generic Pharmaceuticals – Project Revive DCE/DSW regions – 01/04/27 to 31/01/29 (22 months) DLS/DNE regions – 01/04/27 to 31/01/29 (22 months) DLN/DNW regions – 01/04/27 to 31/01/29 (22 months)
Orthotic Splints & Braces
Location: West MidlandsBuyer: The Shrewsbury and Telford Hospital NHS Trust
Open tenderCloses 13 Nov, 20269 daysValue £60.14kSource Find a TenderOrthotic Splints & Braces - RJAH, SATH , SCT
UKRI-6412 MRC Harwell Self-Steam Generating Autoclave
Location: South WestBuyer: UK Research & Innovation (UKRI)
Open tenderCloses 30 Nov, 202626 daysValue £150.00kSource Find a TenderMRC Harwell is seeking to replace the existing autoclave with the supply, installation and acceptance of a self-steaming generating autoclave
Cleanroom Consumables
Location: West MidlandsBuyer: The Shrewsbury and Telford Hospital NHS Trust
Open tenderCloses 9 Nov, 20265 daysValue £11.91kSource Find a TenderCleanroom Consumables - SATH & SCT
MED0014 - The Supply of Beating Heart Products
Location: United KingdomBuyer: University Hospitals of North Midlands NHS Trust
Open tenderCloses 16 Nov, 202612 daysValue £18.33kSource Find a TenderBeating heart surgery (Off-Pump Coronary Artery Bypass or OPCAB) utilizes specific stabilization equipment rather than a cardiopulmonary bypass machine.